TransformingDrugDiscoveryandDevelopment
Asset42
Asset42, an AI-powered drug asset exchange platform designed to identify and revive unattended and underexplored pharmaceutical assets. Acting as a conduit between innovation and investment, Asset42 reignites promising therapies and their path to commercialization for originators and investors
Meta-D3
Meta-D3 is redefining how pharmaceutical companies approach drug discovery and developement. Covering the entire journey from early-stage innovation to late-stage clinical development, it enables target identification, de novo molecule generation, ADC and PROTAC design, and antibody engineering; advances asset optimization through indication expansion and drug reformulation; and boosts late-stage success with a powerful clinical trial prediction module
Ontosight® AI
Ontosight.ai is your AI partner in research, delivering citation-backed answers from biomedical literature, patents, and clinical data. Ask complex scientific questions and get expert-level insights in seconds. With AI-driven summaries, knowledge synthesis, and semantic search, Ontosight.ai supports scientific and medical professionals work smarter and discover faster
Book a Demo
Contact Us